Safety, Reactogenicity, and Immunogenicity of Different Doses of 10-Valent Extraintestinal Pathogenic Escherichia Coli (expec10v) Bioconjugate Vaccine (VAC52416) in Healthy Japanese Adults Aged 60 to 85 Years in a Randomized, Double-Blind, Phase 1 Study.
Journal of Infection and Chemotherapy（2024）
Key words
ExPEC10V,Safety,Reactogenicity,Immunogenicity,Japanese population
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined